SARAH SATTERFIELD: Open Payments
NPI 1649042680 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 79 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,400 · 2025 $1,659
Food & beverage: $1,575Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $336 |
| ABBVIE INC. | 17 | $312 |
| Regeneron Healthcare Solutions, Inc. | 8 | $189 |
| Madrigal Pharmaceuticals | 5 | $109 |
| Phathom Pharmaceuticals, Inc. | 7 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $82 |
| Gilead Sciences, Inc. | 4 | $79 |
| PFIZER INC. | 5 | $76 |
| Intercept Pharmaceuticals, Inc. | 4 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, VOQUEZNA, RINVOQ, ENTYVIO, OCALIVA, MAVYRET.
Industry payments across GA — which companies pay providers there.
